A Dengue Vaccine: Will It be Accepted and Is It Feasible? Lessons from Barranquilla, Colombia, and Merida, Venezuela.
Colombia
dengue vaccines
feasibility studies
venezuela
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
16 Oct 2019
16 Oct 2019
Historique:
received:
17
09
2019
revised:
08
10
2019
accepted:
09
10
2019
entrez:
19
10
2019
pubmed:
19
10
2019
medline:
19
10
2019
Statut:
epublish
Résumé
With one vaccine on the market and others in clinical trials, policy makers in dengue endemic regions face the decision of whether to introduce a dengue vaccine in their communities. The World Health Organization (WHO) recommends that individualized assessments be conducted before any vaccine introduction to evaluate disease burden and the strength of current vaccination programs. This study seeks to aid in that decision-making process by examining the acceptability and feasibility of dengue vaccine introduction in Barranquilla, Colombia, and Merida, Venezuela. Surveys were administered February-June of 2018 for three groups: patients (
Identifiants
pubmed: 31623165
pii: microorganisms7100458
doi: 10.3390/microorganisms7100458
pmc: PMC6843364
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIH HHS
ID : UL1-TR-001876 and KL2-TR-001877
Pays : United States
Organisme : The Synergist Non Profit in Brussles, Belgium
ID : NA
Références
Lancet Infect Dis. 2019 May;19(5):e149-e161
pubmed: 30799251
Am J Trop Med Hyg. 2010 Jan;82(1):128-35
pubmed: 20065008
PLoS Negl Trop Dis. 2013 Sep 26;7(9):e2261
pubmed: 24086776
PLoS Negl Trop Dis. 2015 Mar 19;9(3):e0003499
pubmed: 25790245
Rev Panam Salud Publica. 2019 Jun 07;43:e49
pubmed: 31171921
Am J Trop Med Hyg. 2014 Nov;91(5):1039-48
pubmed: 25223944
Wkly Epidemiol Rec. 2016 Jul 29;91(30):349-64
pubmed: 27476189
Hum Vaccin Immunother. 2019;15(3):625-627
pubmed: 30309284